Suchergebnisse - "Nair, Jayakumar R."

PubPharm (27)

1

BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor–resistant BRCA-mutant ovarian cancer

enthalten in: bioRxiv.org | 2024

von Gupta, N. | Huang, T. | Nair, J. | +14

2

The CHK1 inhibitor prexasertib in BRCA wild-type platinum-resistant recurrent high-grade serous ovarian carcinoma : a phase 2 trial

enthalten in: Nature communications | 2024

von Giudice, E. | Huang, T. | Nair, J. | +16

3

AKT1 interacts with DHX9 to Mitigate R Loop-Induced Replication Stress in Ovarian Cancer

enthalten in: Cancer research | 2024

von Huang, T. | Chiang, C. | Nair, J. | +3

4

BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor-resistant BRCA-mutant ovarian cancer

enthalten in: Science translational medicine | 2023

von Gupta, N. | Huang, T. | Nair, J. | +14

5

Distinct roles of treatment schemes and BRCA2 on the restoration of homologous recombination DNA repair and PARP inhibitor resistance in ovarian cancer

enthalten in: Oncogene | 2022

von Huang, T. | Burkett, S. | Tandon, M. | +5

6

Targeting the PI3K/mTOR Pathway Augments CHK1 Inhibitor-Induced Replication Stress and Antitumor Activity in High-Grade Serous Ovarian Cancer

enthalten in: Cancer research | 2020

von Huang, T. | Brill, E. | Nair, J. | +5

7

Combination of PARP Inhibitor Olaparib, and PD-L1 Inhibitor Durvalumab, in Recurrent Ovarian Cancer : a Proof-of-Concept Phase II Study

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2020

von Lampert, E. | Zimmer, A. | Padget, M. | +15

8

Patients with BRCA mutated ovarian cancer may have fewer circulating MDSC and more peripheral CD8+ T cells compared with women with BRCA wild-type disease during the early disease course

enthalten in: Oncology letters | 2019

von Lee, J. | Botesteanu, D. | Tomita, Y. | +9

9

CD28 Promotes Plasma Cell Survival, Sustained Antibody Responses, and BLIMP-1 Upregulation through Its Distal PYAP Proline Motif

enthalten in: Journal of immunology (Baltimore, Md. : 1950) | 2015

von Rozanski, C. | Utley, A. | Carlson, L. | +11

10

CD28 Promotes Plasma Cell Survival, Sustained Antibody Responses, and BLIMP-1 Upregulation through Its Distal PYAP Proline Motif

enthalten in: The journal of immunology | 2015

von Rozanski, C. | Utley, A. | Carlson, L. | +11